Drug Patents owned by Catalyst Pharms

1. Drug name - FIRDAPSE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11060128 CATALYST PHARMS Methods of administering 3,4-diaminopyridine Jun, 2032

(9 years from now)

US10793893 CATALYST PHARMS Methods of administering 3,4-diaminopyridine Apr, 2034

(11 years from now)

Drugs and Companies using AMIFAMPRIDINE PHOSPHATE ingredient

Treatment: Method of treating lambert-eaton myasthenic syndrome with amifampridine

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 10MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.